Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 1/20 | 0.31 |
| ▸ | PREP | P48147 | 1/20 | 0.31 |
| ▸ | FAP | Q12884 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7942433 | 0.86 | KDM4E (0.36) | DPP4PREPFAPKDM4EATM | |
| SCHEMBL7930805 | 0.83 | ALDH1A1 (0.37) | — | |
| SCHEMBL24591926 | 0.83 | HPGD (0.32) | — | |
| SCHEMBL2293885 | 0.79 | MLYCD (0.37) | DPP4PREPFAPKDM4EATM | |
| SCHEMBL12448140 | 0.79 | MLYCD (0.39) | DPP4PREPFAPKDM4EATM | |
| SCHEMBL24591881 | 0.78 | HPGD (0.33) | DPP4PREPFAPKDM4EATM | |
| SCHEMBL26894534 | 0.78 | — | — | |
| SCHEMBL26742774 | 0.78 | CHRNB2 (0.41) | — | |
| SCHEMBL20763391 | 0.77 | HPGD (0.39) | DPP4PREPFAPKDM4EATM | |
| SCHEMBL18718047 | 0.77 | CHRM1 (0.37) | DPP4PREPFAPKDM4EATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190209702-A1 | STEROIDS AND ANTIBODY-CONJUGATES THEREOF | REGENERON PHARMACEUTICALS, INC. | 2019-07-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190209702-A1 | STEROIDS AND ANTIBODY-CONJUGATES THEREOF | SERPINA6, NR3C1, NR3C2 | DPP4 3121/4885PREP 3789/4885FAP 2921/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.